Tryptamine to plug $6M placement funding into acceleration of IV-infused psilocybin treatment trials
Tryptamine Therapeutics Ltd (ASX:TYP) is aiming to raise $6 million through a…
Tryptamine Therapeutics Limited (ASX:TYP)
About Tryptamine Therapeutics Limited
Key Information
TYP In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 19/05/2025 | Notification of cessation of securities - TYP | 14.21KB | 297 |
| 16/05/2025 | Release from Escrow | 216.84KB | 306 |
| 14/05/2025 | Initial Director's Interest Notice - HJ | 3.22KB | 256 |
| 14/05/2025 | Final Director's Interest Notice - MD | 3.55KB | 230 |
| 12/05/2025 | Herwig Janssen appointed as Chair and Director transition | 293.11KB | 4.8K |
| 30/04/2025 | Price Sensitive PS Quarterly Activities Report and Appendix 4C | 469.52KB | 387 |
| 10/04/2025 | Price Sensitive PS TRP-8803 BED trial to commence with Swinburne this quarter | 271.66KB | 2.2K |
| 03/04/2025 | Change in substantial holding | 265.39KB | 320 |